Ashwagandha and Man Boobs: Risks Explained

Ashwagandha causing man boobs is a concern raised by a growing number of men using this popular adaptogenic supplement. Ashwagandha (Withania somnifera) is widely sold in UK health food shops and online as a food supplement, and while it is generally considered safe, a small number of case reports have linked it to gynaecomastia, the development of excess breast tissue in men. Understanding the proposed hormonal mechanisms, who may be most at risk, and what steps to take if symptoms appear is important for anyone considering or currently using this supplement.

Can ashwagandha cause man boobs or breast tissue growth in men?

Ashwagandha has been linked to gynaecomastia in a small number of case reports, with a biologically plausible mechanism involving raised testosterone and subsequent oestradiol conversion, though causation has not been confirmed.

Ashwagandha has been linked in a small number of published case reports to gynaecomastia, the medical term for the development of excess breast tissue in men, though a definitive causal relationship has not been established.^[4] Ashwagandha (Withania somnifera) is an adaptogenic herb widely used in Ayurvedic medicine and sold in the UK as a food supplement. Most UK ashwagandha products are regulated as food supplements under UK food law, overseen by the Food Standards Agency (FSA) and the Office for Product Safety and Standards (OPSS).^[19] The MHRA regulates ashwagandha only where a product holds a Traditional Herbal Registration (THR); the majority of products on sale do not hold such a registration and are not subject to the same pre-market safety and efficacy assessment as licensed medicines.^[2][3]

The proposed mechanism centres on ashwagandha's influence on the hormonal axis. Some research suggests the herb may modestly raise testosterone levels and, through a process called aromatisation, elevated testosterone can be converted to oestradiol (a form of oestrogen). An imbalance between oestrogen and testosterone at the level of breast tissue is the core driver of gynaecomastia, regardless of cause. This mechanism is biologically plausible but has not been confirmed as the route by which ashwagandha might contribute to breast tissue changes in men.

It is important to note that gynaecomastia is a common condition in men of all ages, with many potential causes including puberty, obesity, alcohol use, certain prescribed medicines, and underlying health conditions. Attributing breast tissue changes solely to ashwagandha without ruling out other causes would be premature. If you are concerned about any breast changes, speaking to your GP is the appropriate first step. The NHS provides patient-facing information on gynaecomastia, including its causes and when to seek medical advice.

What does the evidence actually say about gynaecomastia risk?

Evidence is limited to isolated case reports and theoretical hormonal mechanisms; no large clinical trial has investigated gynaecomastia as an outcome of ashwagandha supplementation.

The evidence linking ashwagandha directly to gynaecomastia in men is currently limited to isolated case reports and theoretical hormonal mechanisms, rather than robust clinical trial data. Published case reports have described men developing breast tenderness or visible breast tissue enlargement during periods of ashwagandha supplementation, with symptoms resolving in some cases after stopping the supplement. However, case reports sit at the lower end of the evidence hierarchy and cannot confirm causation; the number of such reports is small and they have not been systematically reviewed.

Clinical trials examining ashwagandha's effects on testosterone have generally used standardised root extracts at doses ranging from 300 mg to 600 mg daily.^[4][5] Some trials, including those using KSM-66 and Sensoril extract formulations, have reported statistically significant increases in serum testosterone compared with placebo, though the magnitude of these increases varies between studies and the clinical significance for breast tissue has not been characterised.^[4][5] No large-scale randomised controlled trial identified in the published literature has specifically investigated gynaecomastia as an outcome.

Ashwagandha also contains withanolides, steroidal lactones that may interact with hormone receptors, though the precise effects in humans remain an active area of research and current evidence is largely preclinical.^[4] The overall picture is one of biological plausibility rather than confirmed risk. Men who are already predisposed to hormonal imbalances, for example those with elevated baseline oestrogen or reduced androgen sensitivity, may theoretically be at greater risk, but this has not been quantified in clinical studies. No specific guidance from NICE or the MHRA has been identified addressing this particular risk, which reflects the current gaps in the evidence base.

Who is most likely to be affected and what should they watch for?

Men with pre-existing hormonal imbalances, liver conditions, obesity, or those taking hormone-related medicines are most at risk; key symptoms include breast tenderness, a firm nipple lump, or nipple discharge.

Men with pre-existing hormonal imbalances are most likely to be affected if ashwagandha does influence the oestrogen-to-testosterone ratio, though the evidence for this remains limited. Groups who may warrant particular caution include men with hypogonadism, those taking hormone-related medications such as testosterone replacement therapy, anti-androgens, spironolactone, finasteride, or dutasteride, men taking anabolic steroids or certain antipsychotics, men with liver conditions (since the liver metabolises oestrogen), and those who are overweight or obese, as adipose tissue is a significant site of aromatisation. This is not an exhaustive list; a review of all prescribed, over-the-counter, and herbal products is appropriate when assessing gynaecomastia risk.

Symptoms to watch for include:

• Breast tenderness or sensitivity, particularly around the nipple area

• Visible swelling or a firm, rubbery lump beneath one or both nipples

• Nipple discharge, which always warrants prompt medical review

• Asymmetrical breast enlargement

It is worth distinguishing true gynaecomastia, which involves glandular breast tissue, from pseudogynaecomastia, which is fatty tissue accumulation without glandular involvement and is more closely associated with excess body weight. A GP can assess which is present through clinical examination and, where appropriate, blood tests to check hormone levels including testosterone, oestradiol, luteinising hormone, and prolactin. NICE Clinical Knowledge Summaries on gynaecomastia provide guidance on the primary-care assessment pathway.

Adolescents and older men are at higher baseline risk of gynaecomastia due to natural hormonal fluctuations at these life stages, so any supplement that may influence hormone levels deserves additional caution in these groups.^[15][16] If breast changes appear during ashwagandha use, they should not be dismissed as cosmetic, as gynaecomastia can occasionally signal an underlying condition requiring investigation. Where features are concerning, such as a hard or irregular lump, skin or nipple changes, blood-stained nipple discharge, nipple inversion, or palpable axillary lymph nodes, a prompt GP appointment is warranted; NICE guidance on suspected cancer (NG12) sets out referral criteria for suspicious male breast symptoms.^[8][9]

Should I stop taking ashwagandha if I notice chest changes?

Yes, stop the supplement and consult your GP promptly; nipple discharge, a hard irregular lump, or rapidly progressive swelling warrant urgent review rather than a wait-and-see approach.

If you notice breast tenderness, swelling, or any lump beneath the nipple while taking ashwagandha, you should stop the supplement and contact your GP for assessment. This is a precautionary step rather than confirmation that ashwagandha is the cause, as many conditions can produce similar symptoms and a clinical evaluation is needed to identify the underlying reason.

Your GP will typically take a full medication and supplement history, examine the breast tissue, and may arrange blood tests to assess hormone levels. It is important to tell your doctor about all supplements you are taking, as these are not always captured in standard medication reviews. Ashwagandha is not a licensed medicine in the UK, so it will not appear on your NHS prescription record.

Some case reports of suspected ashwagandha-associated gynaecomastia have described improvement after stopping the supplement, though the total number of such reports is small and this pattern cannot be generalised with confidence. If breast changes persist after stopping, further investigation is warranted regardless of supplement use. Nipple discharge, rapidly progressive swelling, or a hard, irregular lump should prompt a more urgent GP appointment rather than a wait-and-see approach.

Suspected adverse reactions to food supplements can be reported to the MHRA via the Yellow Card scheme at yellowcard.^[12][13]mhra.gov.uk, which helps regulators monitor the safety of products available in the UK, including unlicensed supplements. Reporting even uncertain reactions contributes to the broader evidence base and may help protect other users. Do not restart the supplement without discussing it with a healthcare professional first.

Safer alternatives and what UK men should consider before supplementing

Discuss supplement use with your GP before starting, choose reputable UK retailers, stick to studied doses of 300 mg to 600 mg daily, and consider evidence-based lifestyle measures for stress and wellbeing instead.

Men considering ashwagandha or any adaptogenic supplement should weigh the limited evidence base against their individual health profile before starting, particularly if they have a history of hormonal conditions or are taking medicines that affect hormone levels. Ashwagandha is sold widely in UK health food shops and online as a food supplement, meaning it does not require a prescription and is not subject to the same pre-market safety and efficacy testing as licensed medicines.

Before supplementing, it is worth considering the following:

• Discuss any planned supplement use with your GP, especially if you have a hormonal condition, liver disease, or are taking prescribed medicines

• Buy from reputable UK retailers; note that there is no official UK quality logo or certification scheme for food supplements, and most ashwagandha products are regulated as food supplements under FSA and OPSS oversight rather than as medicines

• Be cautious of high-dose formulations; most clinical research has used standardised extracts (such as KSM-66 or Sensoril) at 300 mg to 600 mg daily, and effects at higher doses are less well studied

• Avoid combining ashwagandha with other supplements or medicines that may also influence hormone levels without professional guidance

For men seeking support with stress, sleep, or general wellbeing, lifestyle measures including regular physical activity (in line with UK Chief Medical Officers' physical activity guidelines), adequate sleep, and a balanced diet have a well-established evidence base and carry no hormonal risk.^[17][18] NHS resources on sleep hygiene and physical activity provide practical, evidence-based starting points. If fatigue or low mood is the primary concern, a GP assessment to rule out conditions such as hypothyroidism, low testosterone, or depression is a more clinically appropriate starting point than self-supplementation.

Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support, where clinically appropriate treatment options may be considered following a full assessment. For any man uncertain about breast changes or supplement safety, a conversation with a qualified clinician remains the safest course of action.

Scientific References

1. Common questions about anastrozole.
2. Herbal medicines granted a traditional herbal registration (THR).
3. Apply for a traditional herbal registration (THR).
4. Hormonal Modulation with Withania somnifera: Systematic Review and Meta-Analysis of Randomized-controlled Trials.
5. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study.
6. Drug-induced gynecomastia.
7. Estrogens and the human male.
8. Suspected cancer: recognition and referral (NG12).
9. Suspected cancer: recognition and referral (NG12) — recommendations organised by site of cancer.
10. Obesity-Associated Breast Cancer: Analysis of Risk Factors and Current Clinical Evaluation.
11. Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects.
12. Freedom of Information request on adverse event reports (FOI 21/1138).
13. Adverse reactions to drugs.
14. Herbal medicines: report suspected adverse reactions to the Yellow Card Scheme.
15. Peer Victimization and Psychological Outcomes in Adolescents with Pubertal Gynecomastia: A Case-Control Study.
16. Transition from gynaecomastia to lipomastia in pubertal boys.
17. UK Chief Medical Officers' physical activity guidelines.
18. Physical activity guidelines: UK Chief Medical Officers' report.
19. Summary of responses to call for evidence on Ashwagandha.

Frequently Asked Questions